Article (Scientific journals)
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
Schoenen, Jean; Reuter, Uwe; Diener, Hans*-Christoph et al.
2010In Cephalalgia, 30 (11), p. 1290-5
Peer Reviewed verified by ORBi
 

Files


Full Text
Factors predicting Schoenen et al 2010.pdf
Publisher postprint (244.91 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] INTRODUCTION: Demographic and clinical variables were examined in a post hoc analysis of the PROlonged Migraine Prevention with Topiramate (PROMPT) study to determine potential contribution to relapse. METHODS: After a six-month open-label (OL) topiramate phase, patients were randomised to continue topiramate or switch to placebo in a six-month double-blind (DB) phase. 'Relapse' was investigated in terms of change in monthly migraine days after randomisation compared with the month before randomisation, and was analysed during the first ('initial relapse') and last month ('sustained relapse') of the DB phase. More than 40 potential predicting factors were entered into analyses of variance and covariance. RESULTS: For initial relapse, variable-by-treatment interactions were significant for the Headache Impact Test (HIT-6) at DB baseline, and decline in acute medication intake or reporting of 'anxiety' in the OL phase. For sustained relapse, no statistically significant interactions were observed. CONCLUSION: Relapse after topiramate discontinuation in migraine prophylaxis appears to be unaffected by patient characteristics or baseline migraine frequency.
Disciplines :
Neurosciences & behavior
Neurology
Author, co-author :
Schoenen, Jean  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie
Reuter, Uwe
Diener, Hans*-Christoph
Pfeil, Joop
Schwalen, Susanne
Schauble, Barbara
van Oene, Joop
Language :
English
Title :
Factors predicting the probability of relapse after discontinuation of migraine preventive treatment with topiramate.
Publication date :
2010
Journal title :
Cephalalgia
ISSN :
0333-1024
eISSN :
1468-2982
Publisher :
Blackwell Science, Osney Mead Oxford, United Kingdom
Volume :
30
Issue :
11
Pages :
1290-5
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 29 April 2011

Statistics


Number of views
77 (3 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
6
Scopus citations®
without self-citations
4
OpenCitations
 
3

Bibliography


Similar publications



Contact ORBi